Press releases

Eevia Health Plc to present at "Stora Aktiedagarna" in Stockholm

Eevia Health Plc ("Eevia" or "The Company") by the CEO Stein Ulve will present at the event "Stora Aktiedagarna" in Stockholm, which is arranged between March 13th and March 15th 2023 by Aktiespararna.

The purpose of Stora Aktiedagen is to give share investors factual information about the companies that participate in the event.

The CEO and Founder of Eevia Health, Stein Ulve, will present the Company at 8:25 on Wednesday, March 15th, 2023, including some insight into the new strategic development the Company is looking to make related to cellular health and -recycling.

The presentation that will be given is enclosed in pdf format with this press release. A video of the presentation will be distributed after the event.

 For further information, please contact:

Stein Ulve, CEO, Eevia Health Plc                          

Email: stein.ulve@eeviahealth.com                      

Telephone: +358 400 22 5967                         

INFORMATION ABOUT EEVIA HEALTH PLC

Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients in dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.

Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia's other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion.

Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name (ticker) EEVIA.

To learn more, please visit  www.eeviahealth.com or follow Eevia Health on LinkedIn@EeviaHealth. 

2023-05-24
Regulatory

Eevia Health ("Eevia" or "The Company") received a 13K USD /12KEUR sales order for the elderberry extract Feno-Sambucus™ 7 Organic.

2023-05-16

Eevia Health Plc, ("Eevia" or "The Company"), has received a sales order from a European customer of c. 41 KEUR for an organically certified bilberry extract.

2023-05-16
Regulatory

Eevia Health Plc ("Eevia" or "The Company") is releasing its quarterly financial report for the first quarter of 2023.

2023-05-10

Eevia Health Plc ("Eevia" or "The Company") is promoting its products and value proposition by exhibiting at Vitafoods 2023, a key nutraceutical tradeshow in Geneva, Switzerland between 9 - 11 May 2023

2023-05-04
Regulatory

Eevia Health Abp ("Eevia Health" or the "Company") has appointed Mangold Fondkommission to act as a liquidity provider for the company's shares. The assignment commences on Wednesday, May 4th, 2023.

2023-04-26

Eevia Health Plc, ("Eevia" or "The Company"), has received a first sales order from a new customer in Germany of c. 11 KEUR for Feno-Myrtillus® 36 Organic, an organically certified bilberry extract

2023-04-26
Regulatory

Eevia Health Plc ("Eevia" or "The Company") has decided to adjust the planned time for several financial events in 2023.

2023-04-18

Eevia Health ("Eevia" or "The Company") received a 450 KSEK / 40 KEUR sales order for the Feno-Sambucus™ from its Australian distributor Ingredient Plus. The order is the second order from an Australian brand owner.

2023-04-17
Regulatory

Due to a language setting choice in our Cision News portal with both English and Finnish chosen in the original press release, the press release did not go out automatically on all channels at the same time. To ensure the release is available on all channels, we re-release the press release. There are no changes to the substance of the release.

Eevia Health Plc, ("Eevia" or "The Company"), received several new sales orders totaling c. 23.8 MSEK / 2.1 MEUR from an International nutraceutical brand owner for an extract ingredient with immune health properties.

2023-04-17
Regulatory

Eevia Health Plc, ("Eevia" or "The Company"), received several new sales orders totaling c. 23.8 MSEK / 2.1 MEUR from an International nutraceutical brand owner for an extract ingredient with immune health properties.

1
2
...
10
>>